Asia Healthcare Market
Nov 30, 2022
Antibody-Drug Conjugate: The Smart Biological Bomb
Antibody-drug conjugate (ADCs) is a new emerging class of highly potent pharmaceutical drugs, which is a great combination of chemotherapy and immunotherapy. Over the past couple of decades, antibody-drug conjugates have revolutionized the field of cancer chemotherapy. ADCs are composed of 3 parts: an antibody drug...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
